1887

Abstract

Enzootic nasal adenocarcinoma (ENA) is a contagious neoplasm of the nasal mucosa of sheep and goats and is associated with enzootic nasal tumour virus (ENTV). As ENA is a common disease in North America and there are no vaccines against ENTV-1, diagnostic tests that can identify infected animals and assist with eradication and disease surveillance efforts are greatly needed. In this study, we endeavoured to develop a novel, non-invasive diagnostic tool that could be used not only to validate clinical signs of ENA but also to detect ENTV-1 infection prior to the onset of disease signs (i.e. pre-clinical diagnosis). Cytology, serology and reverse transcription (RT)-PCR-based diagnostic methods were investigated. Although the cytology-based assay was able to detect ENTV-1 infection in some animals, it had poor sensitivity and specificity and thus was not developed further as an ante-mortem diagnostic method. Three different assays, including ELISA, Western blotting and virus neutralization, were developed to detect the presence of ENTV-1-specific antibodies in sheep serum. Whilst a surprisingly large number of sheep mounted an antibody-mediated immune response against ENTV-1, and in some cases neutralizing, correlation with disease status was poor. In contrast, RT-PCR on RNA extracted from nasal swabs reliably detected exogenous ENTV-1 sequences, did not amplify endogenous ovine betaretroviral sequences, demonstrated high concordance with immunohistochemical staining for ENTV-1 envelope protein, and had perfect sensitivity and specificity. This report describes a practical and highly specific RT-PCR technique for the detection of clinical and pre-clinical ENA that may prove beneficial in future control or eradication programmes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.064956-0
2014-08-01
2024-12-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/8/1843.html?itemId=/content/journal/jgv/10.1099/vir.0.064956-0&mimeType=html&fmt=ahah

References

  1. Caswell J., Williams K. 2007; Enzootic nasal tumour of sheep. In Palmer’s Pathology of Domestic Animals, 5th edn. pp. 640–643 Edited by Maxie M. Philadelphia, PA: Elsevier Saunders;
    [Google Scholar]
  2. Cousens C., Minguijon E., Garcia M., Ferrer L. M., Dalziel R. G., Palmarini M., De las Heras M., Sharp J. M. 1996; PCR-based detection and partial characterization of a retrovirus associated with contagious intranasal tumors of sheep and goats. J Virol 70:7580–7583[PubMed]
    [Google Scholar]
  3. Cousens C., Minguijon E., Dalziel R. G., Ortin A., Garcia M., Park J., Gonzalez L., Sharp J. M., de las Heras M. 1999; Complete sequence of enzootic nasal tumor virus, a retrovirus associated with transmissible intranasal tumors of sheep. J Virol 73:3986–3993[PubMed]
    [Google Scholar]
  4. De las Heras M., García de Jalón J. A., Minguijón E., Gray E. W., Dewar P., Sharp J. M. 1995; Experimental transmission of enzootic intranasal tumors of goats. Vet Pathol 32:19–23 [View Article][PubMed]
    [Google Scholar]
  5. De las Heras M., Ortín A., Cousens C., Minguijón E., Sharp J. M. 2003; Enzootic nasal adenocarcinoma of sheep and goats. Curr Top Microbiol Immunol 275:201–223[PubMed]
    [Google Scholar]
  6. DeMartini J. C., Carlson J. O., Leroux C., Spencer T., Palmarini M. 2003; Endogenous retroviruses related to Jaagsiekte sheep retrovirus. Curr Top Microbiol Immunol 275:117–137[PubMed]
    [Google Scholar]
  7. Hessell A. J., Rakasz E. G., Tehrani D. M., Huber M., Weisgrau K. L., Landucci G., Forthal D. N., Koff W. C., Poignard P.other authors 2010; Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L. J Virol 84:1302–1313 [View Article][PubMed]
    [Google Scholar]
  8. Miller A. D., Garcia J. V., von Suhr N., Lynch C. M., Wilson C., Eiden M. V. 1991; Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 65:2220–2224[PubMed]
    [Google Scholar]
  9. Miller D. G., Edwards R. H., Miller A. D. 1994; Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A 91:78–82 [View Article][PubMed]
    [Google Scholar]
  10. Ortín A., Minguijón E., Dewar P., García M., Ferrer L. M., Palmarini M., Gonzalez L., Sharp J. M., De las Heras M. 1998; Lack of a specific immune response against a recombinant capsid protein of Jaagsiekte sheep retrovirus in sheep and goats naturally affected by enzootic nasal tumour or sheep pulmonary adenomatosis. Vet Immunol Immunopathol 61:229–237 [View Article][PubMed]
    [Google Scholar]
  11. Palmarini M., Hallwirth C., York D., Murgia C., de Oliveira T., Spencer T., Fan H. 2000; Molecular cloning and functional analysis of three type D endogenous retroviruses of sheep reveal a different cell tropism from that of the highly related exogenous jaagsiekte sheep retrovirus. J Virol 74:8065–8076 [View Article][PubMed]
    [Google Scholar]
  12. Philbey A. W., Cousens C., Bishop J. V., Gill C. A., DeMartini J. C., Sharp J. M. 2006; Multiclonal pattern of Jaagsiekte sheep retrovirus integration sites in ovine pulmonary adenocarcinoma. Virus Res 117:254–263 [View Article][PubMed]
    [Google Scholar]
  13. Rai S. K., Duh F.-M., Vigdorovich V., Danilkovitch-Miagkova A., Lerman M. I., Miller A. D. 2001; Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for Jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci U S A 98:4443–4448 [View Article][PubMed]
    [Google Scholar]
  14. Raimondi G., Turnquist H. R., Thomson A. W. 2007; Frontiers of immunological tolerance. Methods Mol Biol 380:1–24 [View Article][PubMed]
    [Google Scholar]
  15. Spencer T. E., Mura M., Gray C. A., Griebel P. J., Palmarini M. 2003; Receptor usage and fetal expression of ovine endogenous betaretroviruses: implications for coevolution of endogenous and exogenous retroviruses. J Virol 77:749–753 [View Article][PubMed]
    [Google Scholar]
  16. Van Hoeven N. S., Miller A. D. 2005; Improved enzootic nasal tumor virus pseudotype packaging cell lines reveal virus entry requirements in addition to the primary receptor Hyal2. J Virol 79:87–94 [View Article][PubMed]
    [Google Scholar]
  17. Walsh S. R., Linnerth-Petrik N. M., Laporte A. N., Menzies P. I., Foster R. A., Wootton S. K. 2010; Full-length genome sequence analysis of enzootic nasal tumor virus reveals an unusually high degree of genetic stability. Virus Res 151:74–87 (Elsevier B.V.) [View Article][PubMed]
    [Google Scholar]
  18. Walsh S. R., Linnerth-Petrik N. M., Yu D. L., Foster R. A., Menzies P. I., Diaz-Méndez A., Chalmers H. J., Wootton S. K. 2013; Experimental transmission of enzootic nasal adenocarcinoma in sheep. Vet Res 44:66 [View Article][PubMed]
    [Google Scholar]
  19. Wolgamot G., Rasko J. E., Miller A. D. 1998; Retrovirus packaging cells expressing the Mus dunni endogenous virus envelope facilitate transduction of CHO and primary hematopoietic cells. J Virol 72:10242–10245[PubMed]
    [Google Scholar]
  20. Wootton S. K., Metzger M. J., Hudkins K. L., Alpers C. E., York D., DeMartini J. C., Miller A. D. 2006a; Lung cancer induced in mice by the envelope protein of Jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology 3:94 [View Article][PubMed]
    [Google Scholar]
  21. Wootton S. K., Halbert C. L., Miller A. D. 2006b; Envelope proteins of Jaagsiekte sheep retrovirus and enzootic nasal tumor virus induce similar bronchioalveolar tumors in lungs of mice. J Virol 80:9322–9325 [View Article][PubMed]
    [Google Scholar]
  22. Zwick M. B., Labrijn A. F., Wang M., Spenlehauer C., Saphire E. O., Binley J. M., Moore J. P., Stiegler G., Katinger H.other authors 2001; Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 75:10892–10905 [View Article][PubMed]
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.064956-0
Loading
/content/journal/jgv/10.1099/vir.0.064956-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error